St. John's Wort Drug Interactions: The Complete Warning List

St. John's Wort (Hypericum perforatum) is one of the most widely purchased herbal supplements in the world, used primarily for mild to moderate depression. It is also responsible for more clinically significant drug interactions than virtually any other supplement on the market. If you take any prescription medication, this article is essential reading.

How St. John's Wort Causes Interactions

St. John's Wort works against medications through two primary mechanisms:

1. CYP3A4 induction: St. John's Wort strongly upregulates CYP3A4, the liver enzyme responsible for metabolizing approximately 50% of all pharmaceutical drugs. Faster enzyme activity means faster drug breakdown, leading to lower blood levels.

2. P-glycoprotein induction: P-gp is a drug efflux transporter in the gut and brain. By increasing P-gp activity, St. John's Wort actively pumps drugs out of cells and reduces their absorption and tissue penetration.

These effects begin within days of starting and persist for two to three weeks after stopping. They affect a massive range of medications.

Psychiatric Medications: Dual Risk

• SSRIs and SNRIs: Both serotonin syndrome risk (from combined serotonergic activity) AND reduced drug levels from CYP induction. This is the most dangerous psychiatric combination.
• Tricyclic antidepressants: Reduced blood levels from CYP3A4/2C9 induction
• Buspirone: Reduced effectiveness and serotonin syndrome risk
• Benzodiazepines (midazolam, alprazolam): Significantly reduced blood levels
• Antipsychotics (risperidone, quetiapine, clozapine): Substantially reduced levels, potential for psychotic relapse

Cardiovascular Medications

• Warfarin: INR can drop dramatically, increasing clot risk
• Digoxin: Blood levels reduced by up to 33%, risking heart failure or arrhythmia relapse
• Calcium channel blockers (amlodipine, nifedipine, felodipine): Significantly reduced levels, loss of blood pressure control
• Statins (atorvastatin, simvastatin): Reduced cholesterol control

Antiretrovirals (HIV Medications)

St. John's Wort is strictly contraindicated with antiretroviral therapy. It reduces blood levels of protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTIs) by 30–57%, which can allow HIV to replicate and develop drug resistance. This interaction is considered potentially life-threatening.

Immunosuppressants

As discussed in the transplant interactions article, St. John's Wort reduces cyclosporine and tacrolimus levels by 30–64%. This interaction has directly caused documented transplant rejection episodes.

Hormonal Contraceptives

Oral contraceptives, patches, and rings are all metabolized by CYP3A4. St. John's Wort reduces contraceptive hormone levels, documented to cause breakthrough ovulation and unintended pregnancies.

Oncology Medications

Multiple chemotherapy agents are CYP3A4 substrates:

• Irinotecan: Reduced to subtherapeutic levels
• Imatinib (Gleevec): Significantly reduced levels
• Docetaxel, paclitaxel: Reduced levels This is an absolutely contraindicated combination in cancer treatment.

Other Notable Interactions

• Opioids (fentanyl, oxycodone, methadone): Reduced pain control and potential withdrawal in dependent patients
• Triptans (sumatriptan): Serotonin syndrome risk
• Theophylline: Reduced asthma control
• Cyclosporine, tacrolimus: Already covered — organ rejection risk
• Methadone: Reduced levels, potential withdrawal

FAQ

How long do St. John's Wort interactions last after stopping? CYP3A4 and P-glycoprotein induction persists for approximately two to four weeks after stopping St. John's Wort. If you need to start a sensitive medication, discontinue St. John's Wort at least two to three weeks beforehand.

Is a low dose of St. John's Wort safer? Dose-dependent CYP induction is a real phenomenon, but there is no established "safe" dose for people on CYP3A4-sensitive medications. The variability in hypericin and hyperforin content between brands adds further uncertainty. Avoidance is recommended for anyone on affected medications.

Are topical St. John's Wort preparations safe? Topical St. John's Wort (for wound healing or nerve pain) has minimal systemic absorption and is unlikely to cause significant CYP induction. The interaction risk is primarily from oral supplementation.

St. John's Wort is a meaningful supplement for mild depression when used by someone on no medications. For anyone on prescription therapy, it is one of the most dangerous supplements available over the counter.

Related Articles

• What Blocks Calcium Absorption: Supplements and Food Timing
• Fat-Soluble Vitamins: Why Timing and Fat Matter for Absorption
• Grapefruit and Supplements: CYP3A4 Inhibition Explained
• What Blocks Iron Absorption: Calcium, Tannins, and Timing
• Complete Guide to Supplement Timing: Morning, Night, With Food

Track your supplements in Optimize.